SAN DIEGO, April 24, 2018 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced the Company is a
sponsor of the American Association of Neurological Surgeons
(AANS) Annual Scientific meeting being held April 28-May 2,
2018, in New Orleans, at the
Earnest N. Morial Convention Center. NuVasive will host a
hands-on workshop featuring the latest advances in Lateral
Single-Position surgery, technology to reduce OR radiation and
developments in 3D-printed implants.
The NuVasive Industry Lunch and Learn Workshop,
Single-Position Lateral Surgery Solutions to Treat L4-S1,
Featuring Advanced 3D-Printed Implants and LessRay® Radiation
Emission Reduction Technology, by Kaveh
Khajavi, M.D., Robert Issacs,
M.D. and Juan Uribe, M.D., will take
place on Monday, April 30 from
1:10-1:55 p.m. in Room 272-273. For
more information, visit the AANS Program Schedule.
"The interactive workshop provides a forum to discover our
commitment to Safer, Faster and Smarter surgery through Surgical
Intelligence as well as our leadership position in Lateral
Single-Position surgery and how it fits in with our
industry-leading lateral procedural solutions," said Matt Link, executive vice president, strategy,
technology and corporate development for NuVasive. "Lateral
Single-Position benefits include reducing the number of times a
patient has to be repositioned for greater OR efficiency. Attendees
will hear directly from early adopters of the technology and also
learn what NuVasive is doing to incorporate advanced materials into
its surgical implants and how Surgical Intelligence includes
proactively combatting radiation exposure in the OR with LessRay
technology."
Additionally, AANS attendees can visit NuVasive Booth #529 to
experience the latest innovative spine solutions and systems
firsthand from the NuVasive team of experts and meet NFL great and
NuVasive spokesperson Archie
Manning. The College Hall of Fame and former NFL Pro Bowl
quarterback will discuss his firsthand experience with the
life-changing NuVasive XLIF® procedure at the Lunch and Learn and
in the booth on Monday, April 30.
Manning continues to proudly share his personal story of how the
XLIF spine procedure changed his life by restoring height and
stability to the collapsed disc space on the left side of his
lumbar spine. XLIF is the leading lateral spine procedure,
supported by over 10 years of clinical evidence.
Individual NuVasive booth stations will focus on a variety of
spine solutions, including Lateral Single-Position Surgery,
Surgical Intelligence, Advanced Materials Science™, Cervicothoracic
and TLIF.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, focused on transforming spine surgery and beyond with
minimally disruptive, procedurally-integrated solutions designed to
deliver reproducible and clinically-proven surgical outcomes. The
Company's portfolio includes access instruments, implantable
hardware, biologics, software systems for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative monitoring
service offerings. With over $1
billion in revenues, NuVasive has an approximate 2,400
person workforce in more than 40 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release
that are not a description of historical facts are forward-looking
statements that involve risks, uncertainties, assumptions and other
factors which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from historical
results or those expressed or implied by such forward-looking
statements. The potential risks and uncertainties which contribute
to the uncertain nature of these statements include, among others,
risks associated with acceptance of the Company's surgical products
and procedures by spine surgeons, development and acceptance of new
products or product enhancements, clinical and statistical
verification of the benefits achieved via the use of NuVasive's
products (including the iGA® platform), the Company's ability to
effectually manage inventory as it continues to release new
products, its ability to recruit and retain management and key
personnel, and the other risks and uncertainties described in
NuVasive's news releases and periodic filings with the Securities
and Exchange Commission. NuVasive's public filings with the
Securities and Exchange Commission are available at www.sec.gov.
NuVasive assumes no obligation to update any forward-looking
statement to reflect events or circumstances arising after the date
on which it was made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-sponsors-aans-2018-hosts-workshops-and-presentations-on-latest-innovations-300635707.html
SOURCE NuVasive, Inc.